Evan A Stein, MD PhD
LIB Therapeutics
6
0
4
N/A
0
3
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (6)
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Penny M Kris-Etherton, PhD
Penn State University
Shared therapeutic areas:
Zhaoping Li, MD, PhD
University of California, Los Angeles
Shared therapeutic areas:
Amir Lerman, MD
Mayo Clinic
Shared therapeutic areas:
Harry Hemingway, FRCP
University College, London
Shared therapeutic areas:
Kevin Volpp, MD, PhD
University of Pennsylvania
Shared therapeutic areas:
Michael S Avidan, MBBcH
Washington University School of Medicine
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Ebru Calik Kutukcu, PhD
Hacettepe University
Shared therapeutic areas:
Mitesh Patel, MD, MBA, MS
University of Pennsylvania
Shared therapeutic areas:
Christelle Haziza, PhD
Philip Morris Products S.A.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (6)
Showing 6 of 6 trials
Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients
Trial to Evaluate Efficacy and Safety of LIB003, Evolocumab and Alirocumab in High-risk CVD Patients
Study of Efficacy and Safety of LIB003 in Patient With CVD on Statins Requiring Additional LDL-C Reduction
Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction
Phase 3 Study to Evaluate the Efficacy and Safety of LIB003 With Evolocumab in HoFH
Open-Label Extension to Evaluate the Longer Term Efficacy and Safety of LIB003
All 6 trials loaded